These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 19440145)

  • 21. Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.
    Tsukahara M; Nagai H; Kamiakito T; Kawata H; Takayashiki N; Saito K; Tanaka A
    Pathol Int; 2005 Feb; 55(2):63-9. PubMed ID: 15693851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
    Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
    Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
    Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H
    Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
    Nishikawa N; Kimura Y; Okita K; Zembutsu H; Furuhata T; Katsuramaki T; Kimura S; Asanuma H; Hirata K
    J Hepatobiliary Pancreat Surg; 2006; 13(4):327-35. PubMed ID: 16858545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological features and surgical outcomes of intraductal tubulopapillary neoplasm of the pancreas: a systematic review.
    Date K; Okabayashi T; Shima Y; Iwata J; Sumiyoshi T; Kozuki A; Morita S; Hata Y; Noda Y; Nishioka A; Matsumoto M
    Langenbecks Arch Surg; 2016 Jun; 401(4):439-47. PubMed ID: 27001682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.
    Basturk O; Berger MF; Yamaguchi H; Adsay V; Askan G; Bhanot UK; Zehir A; Carneiro F; Hong SM; Zamboni G; Dikoglu E; Jobanputra V; Wrzeszczynski KO; Balci S; Allen P; Ikari N; Takeuchi S; Akagawa H; Kanno A; Shimosegawa T; Morikawa T; Motoi F; Unno M; Higuchi R; Yamamoto M; Shimizu K; Furukawa T; Klimstra DS
    Mod Pathol; 2017 Dec; 30(12):1760-1772. PubMed ID: 28776573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Senescence in intraductal papillary mucinous neoplasm of the pancreas.
    Miyasaka Y; Nagai E; Ohuchida K; Fujita H; Nakata K; Hayashi A; Mizumoto K; Tsuneyoshi M; Tanaka M
    Hum Pathol; 2011 Dec; 42(12):2010-7. PubMed ID: 21733551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human pancreatic mucinous cystadenoma is characterized by distinct mucin, cytokeratin and CD10 expression compared with intraductal papillary-mucinous adenoma.
    Handra-Luca A; Fléjou JF; Rufat P; Corcos O; Belghiti J; Ruszniewski P; Degott C; Bedossa P; Couvelard A
    Histopathology; 2006 Jun; 48(7):813-21. PubMed ID: 16722930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different patterns of p16INK4A and p53 protein expressions in intraductal papillary-mucinous neoplasms and pancreatic intraepithelial neoplasia.
    Abe K; Suda K; Arakawa A; Yamasaki S; Sonoue H; Mitani K; Nobukawa B
    Pancreas; 2007 Jan; 34(1):85-91. PubMed ID: 17198188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic challenge: intraductal neoplasms of the pancreatobiliary system.
    Tajiri T; Tate G; Matsumoto K; Hoshino H; Iwamura T; Kodaira Y; Takahashi K; Ohike N; Kunimura T; Mitsuya T; Morohoshi T
    Pathol Res Pract; 2012 Nov; 208(11):691-6. PubMed ID: 23057996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
    Adsay V; Jang KT; Roa JC; Dursun N; Ohike N; Bagci P; Basturk O; Bandyopadhyay S; Cheng JD; Sarmiento JM; Escalona OT; Goodman M; Kong SY; Terry P
    Am J Surg Pathol; 2012 Sep; 36(9):1279-301. PubMed ID: 22895264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy.
    Nakamura A; Horinouchi M; Goto M; Nagata K; Sakoda K; Takao S; Imai K; Kim YS; Sato E; Yonezawa S
    J Pathol; 2002 Jun; 197(2):201-10. PubMed ID: 12015744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A rare case of intraductal tumor of the pancreas in which an intraductal tubulopapillary neoplasm was mixed with a widely spreading gastric-type intraductal papillary-mucinous neoplasm].
    Wakabayashi T; Shirota Y; Takeda Y; Hodo Y; Ueda Y
    Nihon Shokakibyo Gakkai Zasshi; 2024; 121(5):415-424. PubMed ID: 38735750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraductal tubular adenomas (pyloric gland-type) of the pancreas: clinicopathologic features are similar to gastric-type intraductal papillary mucinous neoplasms and different from intraductal tubulopapillary neoplasms.
    Chang X; Jiang Y; Li J; Chen J
    Diagn Pathol; 2014 Sep; 9():172. PubMed ID: 25245835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical characteristics and malignant progression of hepatic cystic neoplasms in comparison with pancreatic counterparts.
    Matsubara T; Sato Y; Sasaki M; Harada K; Nomoto K; Tsuneyama K; Nakamura K; Gabata T; Matsui O; Nakanuma Y
    Hum Pathol; 2012 Dec; 43(12):2177-86. PubMed ID: 22705005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma.
    Lüttges J; Zamboni G; Longnecker D; Klöppel G
    Am J Surg Pathol; 2001 Jul; 25(7):942-8. PubMed ID: 11420467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally?
    Nara S; Shimada K; Sakamoto Y; Esaki M; Kosuge T; Hiraoka N
    J Am Coll Surg; 2009 Nov; 209(5):614-21. PubMed ID: 19854402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas.
    Furukawa T; Fujisaki R; Yoshida Y; Kanai N; Sunamura M; Abe T; Takeda K; Matsuno S; Horii A
    Mod Pathol; 2005 Aug; 18(8):1034-42. PubMed ID: 15832194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraductal oncocytic papillary neoplasm of the bile duct: clinicopathologic and immunohistochemical characteristics of 6 cases.
    Tanaka M; Fukushima N; Noda N; Shibahara J; Kokudo N; Fukayama M
    Hum Pathol; 2009 Nov; 40(11):1543-52. PubMed ID: 19540556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraductal Tubulopapillary Neoplasm of the Pancreas: A Clinicopathologic and Immunohistochemical Analysis of 33 Cases.
    Basturk O; Adsay V; Askan G; Dhall D; Zamboni G; Shimizu M; Cymes K; Carneiro F; Balci S; Sigel C; Reid MD; Esposito I; Baldaia H; Allen P; Klöppel G; Klimstra DS
    Am J Surg Pathol; 2017 Mar; 41(3):313-325. PubMed ID: 27984235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.